There is a tug-of-war going on between the European Commission, with laws intended to protect the free market, and business sectors hoping to claim (or retain) exclusivity. National EU governments are using those laws to their advantage to obtain prescription drugs for the lowest prices.
Details
The healthcare reform bill was only passed at the end of March but its effects are already being reported by some of the biggest players in the pharmaceutical industry
Details
Comparative effectiveness has really come to the fore following the Healthcare Reform Bill and has the potential to seriously affect businesses in the healthcare industry. But is it all just a misunderstood can of worms?
Details
The future of medical publishing might be e-publishing. Will there be a role for print journals?
Details
From e-books on Amazon.com to a new publishing format by the BMJ, e-reading is here to stay, and things will never be the same in medical publications.
Details
You can prove just about anything with statistics. We’ve seen this in polls, politics, and policy. Even in health economics, caveat emptor.
Details
We’ve all seen our share of silly headlines or sound bites, but they become a more serious matter when health or money is at stake.
Details
The UK National Institute for Health and Clinical Excellence (NICE) has overhauled its technology appeals process with the aim of making it quicker and slicker. Despite the efforts at greater clarity, the short period for appealing final decisions remains, so time is of the essence.
Details
Updated guidance on the appeals process for technology appraisals doesn’t exactly conjure up sexy headlines, but the process affects everyone – manufacturer, provider, and patient – so it’s worth the read.
Details
With the growing push toward used of electronic health records (EHRs), a recent study looked at whether the computer will get in the way of the physician-patient interaction – literally or figuratively.
Details
